Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study

IntroductionDonor choosing remains to play a pivotal role in allogeneic hematopoietic stem cell transplantation (allo-HSCT). Numerous criteria beyond HLA compatibility impact the selection of a suitable donor.MethodsWe evaluated the effect of donor parity on transplant outcomes in a large homogeneou...

Full description

Bibliographic Details
Main Authors:	Mojtaba Azari, Maryam Barkhordar, Tanaz Bahri, Soroush Rad, Hosein Kamranzadeh Fumani, Seied Asadollah Mousavi, Sahar Tavakoli Shiraji, Morteza Azari, Parisa Shafaroudi, Mohammad Vaezi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Oncology
Subjects:	graft-versus-host disease (GVHD) hematopoietic stem cell transplantation (HSCT) donor parity overall survival relapse incidence
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1339605/full

Similar Items

Corrigendum: Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study
by: Mojtaba Azari, et al.
Published: (2024-04-01)

Clinical Features and Risk Factors of Relapse and Mortality in Thrombotic Thrombocytopenic Purpura Patients: A Seven-Year Experience
by: Sahar Tavakoli Shiraji, et al.
Published: (2023-07-01)

Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia
by: Maryam Barkhordar, et al.
Published: (2022-08-01)

Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the Coronavirus Disease 2019 (COVID-19) Pandemic: An Iranian Consensus
by: Seied Asadollah Mousavi, et al.
Published: (2020-07-01)

Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation
by: Maryam Barkhordar, et al.
Published: (2021-01-01)

Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran.
by: Seied Asadollah Mousavi, et al.
Published: (2019-01-01)

Comparable Outcomes of Pre- Versus Post-Tyrosine Kinase Inhibitor Era Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With Long-term Follow-up
by: Sahar Tavakoli, et al.
Published: (2023-04-01)

Sixteen Years of Experience with the Treatment of Advanced Colorectal Cancer in Iran; A Report from Three Institutions
by: Hasan Jalaeikhoo, et al.
Published: (2018-07-01)

Analysis of Correlation between Body Mass Index and the Incidence of Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
by: Masoud Soleimani, et al.
Published: (2021-09-01)

Impact of the Recipient’s Pre-Treatment Blood Lymphocyte Count on Intended and Unintended Effects of Anti-T-Lymphocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation
by: Alexander Nikoloudis, et al.
Published: (2023-07-01)

Successful Outcome of Autologous Stem Cell Transplantation for Relapsed or Refractory Germ Cell Tumors
by: Seied Asadollah Mousavi, et al.
Published: (2018-07-01)

Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD
by: Yin Liu, et al.
Published: (2022-11-01)

The role of animal models in the study of hematopoietic stem cell transplantation and GvHD: A historical overview.
by: Margherita Boieri, et al.
Published: (2016-08-01)

Biomarkers for early complications post hematopoietic cell transplantation: Insights and challenges
by: Balaji Balakrishnan, et al.
Published: (2023-02-01)

The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety
by: Xiaoli Chen, et al.
Published: (2021-09-01)

Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation
by: Xiaoyu Zhang, et al.
Published: (2022-12-01)

Effectiveness of adjuvant chemotherapy in patients with Stage II colorectal cancer: A multicenter retrospective study
by: Hasan Jalaeikhoo, et al.
Published: (2019-01-01)

Longitudinal Changes of Ocular Surface Microbiome in Patients Undergoing Hemopoietic Stem Cell Transplant (HSCT)
by: Suzanne Clougher, et al.
Published: (2023-12-01)

Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation
by: Shabnam Shokouhi, et al.
Published: (2015-09-01)

Spontaneous Complete Remission of Acute Myeloid Leukemia in the Absence of Disease-Modifying Therapy following Severe Pulmonary Involvement by Coronavirus Infectious Disease-19
by: Maryam Barkhordar, et al.
Published: (2022-01-01)

Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review
by: Abhinav Bhattarai, et al.
Published: (2024-12-01)

The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors
by: M. Remberger, et al.
Published: (2020-03-01)

Editorial: Rising stars: cell and stem cell transplantation 2022
by: Raffaella Greco, et al.
Published: (2024-01-01)

A genome-wide association study on hematopoietic stem cell transplantation reveals novel genomic loci associated with transplant outcomes
by: Albert Rosenberger, et al.
Published: (2024-02-01)

Increased Level of IFN-γ and IL-4 Spot-Forming Cells on ELISPOT Assay as Biomarkers for Acute Graft-Versus-Host Disease and Concurrent Infections
by: Yoshihiro Komada, et al.
Published: (2012-04-01)

Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation
by: Amandine Pradier, et al.
Published: (2020-05-01)

T-Cell Metabolism in Graft Versus Host Disease
by: Franziska Karl, et al.
Published: (2021-10-01)

Incidence and Prognostic Impact of WT-1 Gene Exon7 and 9 Mutations in Acute Promyelocytic Leukemia
by: Fatemeh Nejatifar, et al.
Published: (2022-04-01)

Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)
by: Tahereh Bakhtiari, et al.
Published: (2023-06-01)

Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response—a prospective, single-arm study
by: Maryam Barkhordar, et al.
Published: (2023-04-01)

Oral Dysplastic Complications after HSCT: Single Case Series of Multidisciplinary Evaluation of 80 Patients
by: Stefania Leuci, et al.
Published: (2020-10-01)

The Benefits of the Post-Transplant Cyclophosphamide in Both Haploidentical and Mismatched Unrelated Donor Setting in Allogeneic Stem Cells Transplantation
by: Jarosław Dybko, et al.
Published: (2023-03-01)

Application prospect of low-dose porcine anti-thymocyte globulin in HLA-matched sibling donor transplantation
by: Xin Chen, et al.
Published: (2023-12-01)

Treatment of steroid-refractory graft versus host disease in children
by: Francesca Gottardi, et al.
Published: (2023-09-01)

Downregulation of the vitamin D receptor expression during acute gastrointestinal graft versus host disease is associated with poor outcome after allogeneic stem cell transplantation
by: Carina Matos, et al.
Published: (2022-10-01)

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
by: Lv Meng, et al.
Published: (2012-03-01)

PRDM1 Drives Human Primary T Cell Hyporesponsiveness by Altering the T Cell Transcriptome and Epigenome
by: Huidong Guo, et al.
Published: (2022-04-01)

Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia
by: Zhenli Huang, et al.
Published: (2022-11-01)

Survival and Functional Immune Reconstitution After Haploidentical Stem Cell Transplantation in Atm-Deficient Mice
by: Ruth Pia Duecker, et al.
Published: (2021-06-01)

Meta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD
by: Kati Hyvärinen, et al.
Published: (2020-02-01)